» Authors » Linda Zaharenko

Linda Zaharenko

Explore the profile of Linda Zaharenko including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 15
Citations 347
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Syundyukov E, Mednis M, Zaharenko L, Pildegovica E, Danovska I, Kistkins S, et al.
Vaccines (Basel) . 2021 Dec; 9(12). PMID: 34960129
Due to the severe impact of COVID-19 on public health, rollout of the vaccines must be large-scale. Current solutions are not intended to promote an active collaboration between communities and...
2.
Kurlovics J, Zake D, Zaharenko L, Berzins K, Klovins J, Stalidzans E
Clin Pharmacokinet . 2021 Jul; 61(1):133-142. PMID: 34309806
Background: Metformin has been used for the treatment of type 2 diabetes for over 60 years; however, its mechanism of pharmacological action is not fully clear. Different hypotheses exist regarding...
3.
Zake D, Kurlovics J, Zaharenko L, Komasilovs V, Klovins J, Stalidzans E
PLoS One . 2021 Apr; 16(4):e0249594. PMID: 33826656
Metformin is the primary drug for type 2 diabetes treatment and a promising candidate for other disease treatment. It has significant deviations between individuals in therapy efficiency and pharmacokinetics, leading...
4.
Ustinova M, Peculis R, Rescenko R, Rovite V, Zaharenko L, Elbere I, et al.
BMC Med Genomics . 2021 Jan; 14(1):18. PMID: 33430853
Background: Type 2 diabetes complications cause a serious emotional and economical burden to patients and healthcare systems globally. Management of both acute and chronic complications of diabetes, which dramatically impair...
5.
Elbere I, Silamikelis I, Dindune I, Kalnina I, Ustinova M, Briviba M, et al.
PLoS One . 2020 Oct; 15(10):e0241338. PMID: 33125401
Background: The study was conducted to investigate the effects of metformin treatment on the human gut microbiome's taxonomic and functional profile in the Latvian population, and to evaluate the correlation...
6.
Ahola A, Radzeviciene L, Zaharenko L, Bulum T, Skrebinska S, Prakapiene E, et al.
Diabetes Res Clin Pract . 2020 Oct; 170:108495. PMID: 33058955
Aims: To investigate the association between depressive symptomatology and health markers in type 1 diabetes. Methods: Four countries from the InterDiane Consortium had adopted the Finnish Diabetic Nephropathy Study protocol,...
7.
Eklund N, Andrianarisoa N, van Enckevort E, Anton G, Debucquoy A, Muller H, et al.
Biopreserv Biobank . 2020 Apr; 18(3):155-164. PMID: 32302498
The Minimum Information About BIobank data Sharing (MIABIS) was initiated in 2012. MIABIS aims to create a common biobank terminology to facilitate data sharing in biobanks and sample collections. The...
8.
Elbere I, Silamikelis I, Ustinova M, Kalnina I, Zaharenko L, Peculis R, et al.
Clin Epigenetics . 2018 Dec; 10(1):156. PMID: 30545422
Background: Metformin is a widely prescribed antihyperglycemic agent that has been also associated with multiple therapeutic effects in various diseases, including several types of malignancies. There is growing evidence regarding...
9.
Elbere I, Kalnina I, Silamikelis I, Konrade I, Zaharenko L, Sekace K, et al.
PLoS One . 2018 Sep; 13(9):e0204317. PMID: 30261008
Background: Metformin is a widely used first-line drug for treatment of type 2 diabetes. Despite its advantages, metformin has variable therapeutic effects, contraindications, and side effects. Here, for the very...
10.
Rovite V, Wolff-Sagi Y, Zaharenko L, Nikitina-Zake L, Grens E, Klovins J
J Epidemiol . 2018 Mar; 28(8):353-360. PMID: 29576601
Background: The Genome Database of the Latvian Population (LGDB) is a national biobank that collects, maintains, and processes health information, data, and biospecimens collected from representatives of the Latvian population....